ask="8.50"
ask_size="500"
average_daily_volume="86206"
bid="6.30"
bid_size="300"
book_value="5.16"
change="+0.11"
change_from_200_day_moving_average="-3.90"
change_from_50_day_moving_average="0.12"
change_from_52_week_high="-10.43"
change_From_52_week_low="1.29"
change_in_percent="+1.47%"
close="7.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.47"
ebitda="-31.93M"
eps_estimate_current_year="-3.59"
eps_estimate_next_quarter="-0.72"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="12088000"
high="7.75"
high_52_weeks="18.03"
last_trade_date="1/31/2017"
last_trade_price="7.60"
last_trade_size="1909"
last_trade_time="4:00pm"
low="7.30"
low_52_weeks="6.31"
market_capitalization="138.27M"
moving_average_200_day="11.50"
moving_average_50_day="7.48"
name="Syndax Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.83"
open="7.46"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-33.92%"
percent_change_from_50_day_moving_average="+1.54%"
percent_change_from_52_week_high="-57.85%"
percent_change_from_52_week_low="+20.42%"
previous_close="7.49"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.45"
price_per_sales="111.69"
revenue="1.22M"
shares_outstanding="18193000"
short_ratio="0.80"
stock_exchange="NMS"
symbol="SNDX"
volume="221616"
weeks_range_52="6.31 - 18.03"
